PEG-Interferon-Beta Formulations
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to a liquid pharmaceutical composition comprising a pegylated IFN-β (PEG-IFN-β), an excipient, a surfactant and a buffer wherein said excipient is a polyol, wherein said surfactant is a non-ionic surfactant and wherein said buffer is a sodium acetate buffer.
39 Citations
51 Claims
-
1-26. -26. (canceled)
-
27. A liquid pharmaceutical composition comprising a pegylated interferon-B (PEG-IFN-β
- ) or muteins or active fragments thereof, an excipient, a surfactant and a buffer wherein said excipient is a polyol, wherein said surfactant is a non-ionic surfactant and wherein said buffer is a sodium acetate buffer.
- View Dependent Claims (28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51)
Specification